Article citationsMore>>

Lordick, F., von Schilling, C., Bernhard, H., Hennig, M., Bredenkamp, R. and Peschel, C. (2003) Phase II Trial of Irinotecan plus Docetaxel in Cisplatin-Pretreated Relapsed or Refractory Oesophageal Cancer. British Journal of Cancer, 89, 630-633. http://dx.doi.org/10.1038/sj.bjc.6601168

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top